Date
1 - 1 of 1
U.S. FDA Accepts for Priority Review the Biologic…
|
https://www.businesswire.com/news/home/20221206006147/en/U.S.-FDA-Accepts-for-Priority-Review-the-Biologics-License-Application-for-Pfizer%E2%80%99s-Respiratory-Syncytial-Virus-Vaccine-Candidate-for-the-Prevention-of-RSV-Disease-in-Older-Adults
All the best, Nelson Vergel Founder DiscountedLabs.com ExcelMale.com |
|
|